Medicare Enrolled
Dr. Syed Ahmed, M.D.
Medical Oncology · Sebring, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ahmed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmed
Dr. Syed Ahmed is a medical oncology specialist in Sebring, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ahmed performed 182,985 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ahmed received a total of $33,388 from 106 pharmaceutical and/or device companies across 1619 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 14% volume in FL
$33,388 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 80993 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗182,985
Medicare services
Top 14% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
50,490 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
38,300 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
15,060 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 13,780 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 13,320 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,991 | $6 | $23 |
| Paclitaxel chemotherapy injection | 8,333 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 7,000 | $43 | $137 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
4,624 | $36 | $108 |
| Inclisiran injection (Leqvio) for cholesterol | 3,692 | $9 | $49 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,816 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,480 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,383 | $8 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,651 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,440 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,209 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
755 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 556 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 553 | $3 | $12 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
435 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
411 | $97 | $378 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
387 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
348 | $48 | $189 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
289 | $2 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $65 | $239 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
223 | $62 | $197 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
168 | $1 | $3 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
157 | $28 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
137 | $16 | $56 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
136 | $22 | $79 |
| New patient office visit, complex (60-74 min) | 130 | $160 | $585 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $132 | $562 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
112 | $21 | $84 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
110 | $16 | $59 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
104 | $54 | $206 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
95 | $137 | $556 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
93 | $49 | $178 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
93 | $2 | $7 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
92 | $7 | $69 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
82 | $9 | $42 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
68 | $5 | $20 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
61 | $3 | $11 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
58 | $1 | $2 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
55 | $42 | $170 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
50 | $24 | $89 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
46 | $24 | $156 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
45 | $67 | $277 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
34 | $120 | $637 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
27 | $62 | $192 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
26 | $4 | $10 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
26 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $140 | $474 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $125 | $453 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
21 | $2 | $8 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $94 | $285 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
17 | $124 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
30.8% high complexity
64.9% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,388
Total received (2018-2024)
Avg $4,770/year across 7 years
Top 17% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
106
Companies
1,619
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,885
2023
$6,413
2022
$4,968
2021
$4,350
2020
$3,448
2019
$3,444
2018
$3,880
Payments by company (2024)
Janssen Biotech, Inc.
$619
PFIZER INC.
$537
Novartis Pharmaceuticals Corporation
$514
AstraZeneca Pharmaceuticals LP
$444
Incyte Corporation
$342
Lilly USA, LLC
$327
Merck Sharp & Dohme LLC
$323
Astellas Pharma US Inc
$282
GlaxoSmithKline, LLC.
$258
GENZYME CORPORATION
$226
Bayer Healthcare Pharmaceuticals Inc.
$221
ABBVIE INC.
$218
E.R. Squibb & Sons, L.L.C.
$187
Celgene Corporation
$162
Alnylam Pharmaceuticals Inc.
$158
Gilead Sciences, Inc.
$153
SOBI, INC
$147
Eisai Inc.
$146
Pharmacosmos Therapeutics Inc.
$146
Genentech USA, Inc.
$142
PharmaEssentia USA Corporation
$129
Ipsen Biopharmaceuticals, Inc
$125
Takeda Pharmaceuticals U.S.A., Inc.
$122
Rigel Pharmaceuticals, Inc.
$112
Amgen Inc.
$80
ARRAY BIOPHARMA INC
$75
JAZZ PHARMACEUTICALS INC.
$63
Alexion Pharmaceuticals, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$60
Kite Pharma, Inc.
$57
Myriad Genetic Laboratories, Inc.
$52
Adaptive Biotechnologies Corporation
$41
Agios Pharmaceuticals, Inc.
$34
SERVIER PHARMACEUTICALS LLC
$34
Exelixis Inc.
$32
TerSera Therapeutics LLC
$31
RECORDATI_RARE_DISEASES_INC.
$31
Tempus AI, Inc
$29
Aveo Pharmaceuticals, Inc.
$26
Dendreon Pharmaceuticals LLC
$25
Mirati Therapeutics, Inc.
$18
Immunocore Limited
$18
Genmab U.S., Inc.
$18
EMD Serono, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Sumitomo Pharma America, Inc.
$15
Veracyte, Inc.
$12
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,673
Novartis Pharmaceuticals Corporation
$2,292
Janssen Biotech, Inc.
$2,247
E.R. Squibb & Sons, L.L.C.
$2,009
Astellas Pharma US Inc
$1,498
PFIZER INC.
$1,437
Amgen Inc.
$1,373
Incyte Corporation
$1,244
Celgene Corporation
$1,047
Genentech USA, Inc.
$1,039
Merck Sharp & Dohme LLC
$936
GENZYME CORPORATION
$929
Lilly USA, LLC
$903
Merck Sharp & Dohme Corporation
$824
Seagen Inc.
$612
Daiichi Sankyo Inc.
$526
Rigel Pharmaceuticals, Inc.
$518
GlaxoSmithKline, LLC.
$472
Bayer HealthCare Pharmaceuticals Inc.
$472
Bayer Healthcare Pharmaceuticals Inc.
$462
Takeda Pharmaceuticals U.S.A., Inc.
$451
Eisai Inc.
$443
Alnylam Pharmaceuticals Inc.
$379
SOBI, INC
$367
Ipsen Biopharmaceuticals, Inc
$333
ARRAY BIOPHARMA INC
$318
Gilead Sciences, Inc.
$310
Alexion Pharmaceuticals, Inc.
$305
Myriad Genetic Laboratories, Inc.
$277
Regeneron Healthcare Solutions, Inc.
$275
Pharmacyclics LLC, An AbbVie Company
$261
ABBVIE INC.
$257
Exelixis Inc.
$252
Seattle Genetics, Inc.
$243
EISAI INC.
$231
AbbVie, Inc.
$206
Stemline Therapeutics Inc.
$180
BeiGene USA, Inc.
$178
PharmaEssentia USA Corporation
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
Pharmacosmos Therapeutics Inc.
$171
Dova Pharmaceuticals
$166
Coherus Biosciences Inc.
$166
Jazz Pharmaceuticals Inc.
$160
TerSera Therapeutics LLC
$146
Foundation Medicine, Inc.
$139
JAZZ PHARMACEUTICALS INC.
$138
PUMA BIOTECHNOLOGY, INC.
$138
MorphoSys, US Inc.
$138
EMD Serono, Inc.
$134
TESARO, Inc.
$133
AbbVie Inc.
$129
G1 Therapeutics, Inc.
$123
Pharmacyclics LLC, an AbbVie Company
$116
Sobi, Inc
$115
Kyowa Kirin, Inc.
$112
Karyopharm Therapeutics Inc.
$112
Deciphera Pharmaceuticals Inc.
$97
Clovis Oncology, Inc.
$93
Janssen Products, LP
$85
Secura Bio, Inc.
$81
ImmunoGen, Inc.
$79
CTI BioPharma Corp.
$79
Dendreon Pharmaceuticals LLC
$76
Kite Pharma, Inc.
$75
Taiho Oncology, Inc.
$73
Adaptive Biotechnologies Corporation
$73
Mirati Therapeutics, Inc.
$58
EUSA Pharma (US) LLC
$56
AMAG Pharmaceuticals, Inc.
$54
Agios Pharmaceuticals, Inc.
$46
Myovant Sciences Inc.
$46
SERVIER PHARMACEUTICALS LLC
$46
AVEO Pharmaceuticals, Inc.
$43
Sysmex Inostics Inc
$43
Global Blood Therapeutics, Inc.
$43
GE HEALTHCARE
$39
Janssen Pharmaceuticals, Inc
$38
SANOFI-AVENTIS U.S. LLC
$34
Spectrum Pharmaceuticals Inc.
$34
RECORDATI_RARE_DISEASES_INC.
$31
Sumitomo Pharma America, Inc.
$31
Puma Biotechnology, Inc.
$29
Acceleron Pharma, Inc.
$29
Helsinn Therapeutics (U.S.), Inc.
$29
Tempus AI, Inc
$29
Blueprint Medicines Corporation
$27
Aveo Pharmaceuticals, Inc.
$26
SECURA BIO, INC.
$25
Acrotech Biopharma Inc.
$24
Servier Pharmaceuticals LLC
$23
GE HealthCare
$22
Apellis Pharmaceuticals, Inc.
$18
Tolmar, Inc.
$18
Immunocore Limited
$18
Genmab U.S., Inc.
$18
TG Therapeutics, Inc.
$18
Heron Therapeutics, Inc.
$18
TAIHO ONCOLOGY, INC.
$17
TOLMAR Pharmaceuticals, Inc.
$16
Epizyme, Inc.
$16
Acrotech Biopharma LLC
$15
INSYS Therapeutics Inc
$12
Veracyte, Inc.
$12
Medtronic Vascular, Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$6
Top 3 companies account for 21.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AMVUTTRA · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Elahere · Empaveli · Enhertu · Epkinly · FARESTON · FARYDAK · FASENRA · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · INCRELEX · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Micra · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
2
County median income
$55,581
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA HIGHLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ahmed is a mixed practice specialist, with above-average Medicare volume (top 14% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmed experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ahmed performed 50,490 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ahmed receive payments from pharmaceutical companies?
Yes. Dr. Ahmed received a total of $33,388 from 106 companies across 1,619 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmed's costs compare to other medical oncologists in Sebring?
Dr. Ahmed's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Sebring
Browse medical oncologists in Sebring ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology